BICO Partners with the Center for Contemporary Sciences to Reduce Animal Testing in Life Sciences
The two organizations will work closely to build support for the bipartisan FDA Modernization Act and reduce animal testing by promoting human-specific medical research technologies that include advanced in-vitro tissue models and 3D bioprinting. Today BICO, a leading bio convergence company, announced a partnership with the Center for Contemporary Sciences (CCS), a research and advocacy organization championing the advancement of human-relevant methodologies in scientific research and drug discovery. Together the two organizations plan to closely align strategy and outreach efforts to